Interferon alfa-n3 Completed Phase 2 Trials for Stage I Multiple Myeloma / Stage II Multiple Myeloma / Stage III Multiple Myeloma / Refractory Multiple Myeloma Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00006244Melphalan, Peripheral Stem Cell Transplantation, and Interleukin-2 Followed by Interferon Alfa in Treating Patients With Advanced Multiple Myeloma